<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202504</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[The interpretation of 2023 ESC guidelines for the management of cardiomyopathies: classification innovation of non-dilated left ventricular cardiomyopathy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.001</link>
<description><![CDATA[The 2023 European Society of Cardiology (ESC) Guidelines for the Management of Cardiomyopathies provide comprehensive guidance on the classification, diagnosis, treatment, and integrated management of cardiomyopathies. Innovatively, the guidelines introduce a new subtype, non-dilated left ventricular cardiomyopathy (NDLVC), emphasizing the critical role of NDLVC phenotypes, genetic testing, and cardiac magnetic resonance (CMR) imaging in the early diagnosis and risk assessment of cardiomyopathies. This approach facilitates more precise identification of cardiomyopathy subtypes and offers novel insights into diagnosis, prognosis evaluation, and risk stratification. It holds promise for delivering earlier and more accurate individualized risk stratification and treatment strategies for NDLVC patients. In this article, the author will focus on the core interpretation of the guidelines regarding the application of CMR and genetic testing in the management of NDLVC, aiming to provide valuable insights for clinicians and radiologists. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Substantia nigra and locus coeruleus neuromelanin magnetic resonance imaging differentiates Parkinson<sup><sup>,</sup></sup>s disease and multiple system atrophy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.002</link>
<description><![CDATA[<b>Objective</b>To use neuromelanin (NM)-MRI of the substantia nigra (SN) and locus coeruleus (LC) to compare NM loss in patients with Parkinson<sup><sup>,</sup></sup>s disease (PD) and multiple system atrophy (MSA). <b>Materials and Methods</b>A total of 114 subjects (including 38 patients with PD, 38 patients with MSA, and 38 age-matched healthy controls (HCs) were retrospectively collected. In the first part, voxels-of-interests (VOIs) of the bilateral SN were automatically traced based on a brain template detection method. Relative contrast ratio (rCR), volume and corrected volume (SN volume divided by the total intracranial volume) of the SN territory were measured. In the second part, rCR of the LC was measured using manually drawn regions-of-interests (ROIs) within the structure. One-way analysis of variance combined with Bonferroni correction was used to conduct post-hoc multiple comparisons to analyze the intergroup differences of the NM-related parameters. The NM parameters of the SN and LC were combined to generate a model using logistic regression method. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance of different single NM parameters and logistic regression model, and the area under the curve (AUC) was calculated. <b>Results</b>Compared to HCs, volume, corrected volume and rCR of the SN, and rCR of the LC were significantly reduced in PD and MSA patients (Bonferroni correction, all <i>P</i> &lt; 0.001). Of note, MSA had significantly lower SN volume and LC rCR than PD (Bonferroni correction, <i>P</i> &lt; 0.001, respectively). The AUC of the corrected volume of the SN to distinguish MSA and HC, PD and HC reached as high as 0.981 and 0.950, respectively. The AUC of the logistic regression model combining the NM measurement of the SN and LC to distinguish MSA and PD reached 0.817. <b>Conclusions</b>The NM volume and contrast measures of the SN and contrast measures of the LC provided subjective and quantitative information to better facilitate differential diagnosis between PD and MSA. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Analysis of characteristics of brain functional network in Crohn<sup><sup>,</sup></sup>s disease patients with chronic abdominal pain based on rs-fMRI graph theory]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.003</link>
<description><![CDATA[<b>Objective</b>To explore the characteristic changes in the topological properties of the chronic pain-related neural network in patients with Crohn<sup><sup>,</sup></sup>s disease (CD) using resting-state functional magnetic resonance imaging (rs-fMRI) combined with graph theory analysis. <b>Materials and Methods</b>A total of 20 chronic abdominal pain CD patients (APCD), 24 abdominal pain-free CD patients (FAPCD), and 30 healthy controls (HC) were included. Rs-fMRI and 3D-T1 data were collected from all subjects, and relevant clinical scale scores and clinical indicators were recorded. The topological indices of the functional network were compared among the three groups, and the correlations between the differences in brain regions and clinical scale scores were analyzed. <b>Results</b>Regarding global metrics, the FAPCD group exhibited lower small-worldness and normalized clustering coefficients compared to the APCD group (<i>P </i>&lt; 0.05); however, neither the APCD group nor the FAPCD group showed significant differences when compared to the HC group (<i>P </i>&gt; 0.05). Regarding nodal metrics, compared with the HC group, the degree centrality (DC) in the right anterior cingulate and paracingulate gyrus was significantly increased in the APCD group (<i>P </i>&lt; 0.05). The DC and nodal efficiency (NE) in the left superior occipital gyrus and right postcentral gyrus were significantly decreased in the FAPCD group compared with the HC group (<i>P</i> &lt; 0.05). Compared with the FAPCD group, the NE in the orbitofrontal region and the DC in the left precentral gyrus were lower in the APCD group (<i>P</i> &lt; 0.05). Additionally, in APCD and FAPCD two combined CD groups, the increase in the visual analogue scale score for pain was associated with an increase in the DC of the left precentral gyrus (<i>r</i> = 0.386, <i>P </i>&lt; 0.05). <b>Conclusions</b>The brain network topology characteristics of CD patients with chronic abdominal pain have changed, especially in DC and NE in specific brain regions. These changes may provide new directions for pain management and further research into the underlying neural mechanisms. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Developing an interpretable model to predict hemorrhagic transformation risk in acute stroke using multiparameter MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.004</link>
<description><![CDATA[<b>Objective</b>To develop an interpretable model to predict the risk of hemorrhagic transformation after endovascular treatment in acute stroke, utilizing multiparameter MRI. <b>Materials and Methods</b>A retrospective analysis was conducted on 274 patients who presented with acute stroke at our hospital. The assessment of hemorrhagic transformation in these patients was performed using CT or MRI 24 hours post-treatment. Utilize the PyRadiomics software to extract 1143 features from diffusion-weighted imaging and an additional 1143 features from perfusion-weighted imaging, and develop a radiomics score (Radscore) based on these extracted features. Utilize SHapley Additive exPlanations (SHAP) to identify the most pertinent features for model development. Develop an interpretable prediction model for assessing the risk of bleeding conversion by employing six distinct machine learning classifiers: gradient boosting classifier, random forest (RF), eXtreme gradient boosting (XGB), adaptive boosting, Gaussian naive Bayes, and logistic regression. Assess the predictive performance of these machine learning models using receiver operating characteristic (ROC) curves and decision curve analysis (DCA). <b>Results</b>Following feature screening and dimensionality reduction, 15 features demonstrating a strong correlation with the transformation of acute ischemic stroke bleeding were identified. Five clinical variables with statistical differences (age, time from onset to MRI examination, NIHSS score on admission, history of diabetes, and history of atrial fibrillation) and radscore were incorporated into the machine learning model. Among the models evaluated, the RF model exhibited the highest predictive performance, achieving an area under the curve (AUC) of 0.928. When the critical value is set at 0.844, the model demonstrates an accuracy of 85.5%, a sensitivity of 83.0%, and a specificity of 88.2%. DCA indicates that the RF model provides a substantial net benefit in predicting the risk of hemorrhagic transformation in cases of acute stroke. <b>Conclusions</b>The interpretable RF model, which integrates multiparameter MRI radiomics with clinical features, enhances the accuracy of predicting the risk of hemorrhagic transformation following mechanical thrombectomy in acute ischemic stroke. This model offers valuable guidance for early clinical intervention and treatment. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Correlation study of atherosclerotic plaques in the middle cerebral artery with recurrent stroke assessed by magnetic resonance vascular wall imaging]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.005</link>
<description><![CDATA[<b>Objective</b>Magnetic resonance vascular wall imaging (MR-VWI) was used to analyze the characteristics of intracranial atherosclerotic plaques in patients with ischemic stroke in the middle cerebral artery region, and to explore the imaging features independently associated with recurrent stroke. <b>Materials and Methods</b>A total of 185 patients with middle cerebral artery atherosclerosis were retrospectively selected from our hospital. All patients completed MR-VWI examination and were determined to have responsible plaque in the middle cerebral artery in the infarction area. According to the clinical and imaging data, the patients were divided into three groups, namely the first stroke group, the recurrent stroke group and the negative stroke group. Plaque characteristics, China Ischemic Stroke Subclassification (CISS), and other imaging indicators were recorded. The differences of clinical data and imaging features among the three groups were compared, and the risk factors related to ischemic stroke recurrence were further screened by logistic regression analysis. The area under the curve (AUC) corresponding to the receiver operating characteristic curve was calculated for the independent correlation factors obtained from the multi-factor analysis. <b>Results</b>A total of 185 patients were included, including 69 patients in the first stroke group, 76 patients in the recurrent stroke group and 40 patients in the negative stroke group. There was no significant difference in gender among the three groups (<i>P</i> &gt; 0.05). Compared with the first stroke group and the stroke negative group, patients in the recurrent stroke group were older (<i>P</i> &lt; 0.05) and had a higher proportion of diabetes (<i>P</i> &lt; 0.05). Compared with the negative stroke group, the proportion of middle-aged and elderly patients over 45 years old in the first stroke group and the recurrent stroke group was higher (<i>P </i>= 0.006, <i>P</i>&lt; 0.001), and the proportion of diabetes in the recurrent stroke group was higher (<i>P </i>= 0.013). Ring-wall plaques were more common in the first stroke group than in the negative stroke group (<i>P </i>= 0.008). In the first stroke group and the recurrent stroke group, the plaque area, plaque load and degree of stenosis were larger, and the number of enhanced plaques was more (<i>P </i>&lt; 0.05). Compared with the recurrent stroke group, the mechanism of stroke in the recurrent stroke group was more inclined to the type of low perfusion/embolus removal disorder in the CISS classification (<i>P </i>= 0.046), and the recurrent stroke group had larger plaque area (<i>P</i> &lt; 0.001), plaque load (<i>P </i>&lt; 0.001), and more obvious stenosis (<i>P</i> &lt; 0.001). Multivariate logistic regression analysis showed that age, plaque area and plaque load were independent risk factors associated with ischemic stroke recurrence in the middle cerebral artery region (<i>P</i> &lt; 0.05). Age [odds ratio, OR = 1.040, 95% confidence interval (<i>CI</i>): 1.007 to 1.074, <i>P </i>= 0.008], plaque area (OR = 1.286, 95% <i>CI</i>: 1.018 to 1.543, <i>P </i>= 0.002), plaque load (OR = 1.586, 95% <i>CI</i>: 1.013 to 2.155, <i>P</i> &lt; 0.001). The AUC of age was 0.658 (95% <i>CI</i>: 0.568 to 0.748), the AUC of plaque area was 0.662 (95% <i>CI</i>: 0.575 to 0.750), and the AUC of plaque load was 0.758 (95% <i>CI</i>: 0.676 to 0.839). The AUC value of the combined detection of the three factors was 0.827 (95% <i>CI</i>: 0.758 to 0.896), which was higher than the AUC value of other independent predictors, and the overall prediction efficiency was the best. <b>Conclusions</b>Age, plaque area and plaque load are independently associated with the recurrence of middle cerebral artery ischemic stroke. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Value of radiomics model based on DCE-MRI combined with blood cell parameters in differentiating Luminal and Non-Luminal breast cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.006</link>
<description><![CDATA[<b>Objective</b>To explore the value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) radiomics model combined with blood cell parameters in differentiating Luminal and Non-Luminal breast cancer (BC). <b>Materials and Methods</b>DCE-MRI of two hundred and twenty-seven patients with pathologically confirmed BC were retrospectively analyzed. The patients were randomly split into a training set (<i>n </i>= 162) and a validation set (<i>n </i>= 65) at a ratio of 7∶3. Patients were divided into the Luminal group (139 cases) and the Non-Luminal group (88 cases) according to the immunohistochemical results. The BC lesions on the pretreatment DCE-MRI served as the basis for the volume of interest for feature extraction. Three models were constructed to differentiate Luminal from Non-Luminal by analyzing radiomic feature, clinical pathological feature, and hematological parameters. These models were Model 1 (radiomics), Model 2 (hematological parameters), and Model 3 (radiomics + hematological parameters), respectively. The discrimination performance of the models was evaluated using the receiver operating characteristic curve. Decision curve analysis was conducted to determine the clinical usefulness of the models by quantifying the net benefits at different threshold probabilities. <b>Results</b>The area under the curve (AUC), sensitivity, and specificity, of Model 3 were 0.840 (0.774 to 0.893), 87.9%, and 71.4% in the training set, and 0.818 (0.703 to 0.903), 87.5%, and 68.0% in the validation set, respectively. The AUC of the Model 1 was better than that of the Model 2 in the both cohorts (0.817 vs. 0.636, 0.838 vs. 0.515, <i>P </i>= 0.001 and <i>P</i> &lt; 0.001), and the AUC of the Model 3 was also better than that of the Model 2 in the both cohorts (0.840 vs. 0.636, 0.818 vs. 0.515, both <i>P</i> &lt; 0.001). The Model 3 and Model 1 were both more beneficial than Model 2 in clinical practice, as illustrated by decision curve analysis. <b>Conclusions</b>The model that integrated the hematological parameters with DCE-MRI radiomics can help differentiate Luminal from Non-Luminal BC, which facilitates the accurate treatment planning for BC. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A clinical study on the prediction of Ki-67 expression status in breast cancer by quantitative parameters combined with apparent diffusion coefficient of synthetic MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.007</link>
<description><![CDATA[<b>Objective</b>To explore the relationship between quantitative parameters of synthetic MRI (SyMRI) before and after enhancement and the expression status of Ki-67 antigen in breast cancer, and to evaluate the predictive efficacy of these parameters combined with apparent diffusion coefficient (ADC) in the expression status of Ki-67. <b>Materials and Methods</b>The clinical and imaging data of 163 patients diagnosed with breast cancer at Xiangyang Central Hospital from March 2023 to October 2024 were retrospectively collected. All patients underwent complete MRI examinations and their tumor natures were confirmed by pathological examination. On the GE workstation, quantitative parameter values of SyMRI before and after enhancement were obtained and recorded, including pre-enhancement T1 value (T1-Pre), pre-enhancement T2 value (T2-Pre), pre-enhancement proton density value (PD-Pre), post-enhancement T1 value (T1-Gd), post-enhancement T2 value (T2-Gd), and post-enhancement PD value (PD-Gd). The relative change rates of relaxation time before and after enhancement were calculated and recorded as ΔT1%, ΔT2%, and ΔPD%. According to the expression status of Ki-67, the collected patients were divided into high expression group (≥ 30%) and low expression group (&lt; 30%). Statistical analysis of the data was performed using SPSS 27 software, with <i>P</i> &lt; 0.05 indicating statistical significance. Qualitative data were analyzed using the chi-square test, and quantitative data were analyzed using the Kolmogorov-Smirnov (K-S) test for normal distribution. Independent sample <i>t</i>-test or non-parametric Mann-Whitney <i>U</i> test was used to compare the differences in MRI parameters between the high and low expression groups of Ki-67. Significant variables were included in binary logistic regression analysis, and the DeLong test was used to evaluate the predictive efficacy of the model for the expression status of Ki-67. <b>Results</b>There were statistically significant differences between the two groups in terms of maximum lesion diameter, ADC value, estrogen receptor, progesterone receptor, time-signal intensity curve (TIC), and treatment plan selection (<i>P</i> &lt; 0.05); However, there were no significant differences in age, human epidermal growth factor receptor (HER-2) expression status, lesion margin and shape, enhancement characteristics, breast gland type, and lymph node metastasis. Regarding SyMRI quantitative parameters, there were statistically significant differences between the high and low expression groups in T1-Pre, T2-Pre, T1-Gd, T2-Gd, and ΔT1% (<i>P</i> &lt; 0.05); While PD-Pre, PD-Gd, ΔT2%, and ΔPD% showed no statistically significant differences between the two groups. Further multivariate logistic regression analysis showed that TIC, T1-Gd, and ADC value had significant statistical significance, with AUCs of 0.608, 0.837, and 0.701, respectively; sensitivities of 52%, 89%, and 85%, respectively; and specificities of 68%, 68%, and 46%, respectively. Additionally, a logistic regression prediction model was established by combining T1-Gd, ADC value, and TIC, which achieved an AUC of 0.881 for predicting the expression status of Ki-67, with a sensitivity of 89% and a specificity of 76%. <b>Conclusions</b>This study demonstrates that T1-Gd, as a non-invasive imaging biomarker, can effectively predict the expression level of Ki-67 in breast cancer in SyMRI quantitative analysis. By integrating ADC values and TIC, the constructed combined prediction model significantly improves the accuracy and efficacy of predicting Ki-67 expression levels in breast cancer. This finding provides a new approach and method for non-invasive assessment of breast cancer cell proliferation activity and treatment response. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Preliminary study of three-dimensions amide proton metastasis imaging in the prediction of pathological grade of hepatocellular carcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.008</link>
<description><![CDATA[<b>Objective</b>To explore the value of three-dimensional amide proton transfer weighted (3D-APTw) imaging in the assessment of the pathological grade of hepatocellular carcinoma (HCC). <b>Materials and Methods</b>A total of 43 patients with surgical pathology confirmed HCC from October 2020 to April 2023 and underwent Edmondson-Steiner grade (grade Ⅰ to Ⅳ) were prospectively recruited. We classified grade Ⅰ and Ⅱ HCC as low grade HCC and grade Ⅲ and Ⅳ lesions as high grade HCC. A Philips 3.0 T MRI device was scanned before surgery to acquire T1WI, T2WI, diffusion-weighted imaging, amide proton transfer weighted (APTw) and multi-stage enhanced images, respectively. APTw values for HCC and hepatplasm were measured independently by two experienced radiologists. Differences between groups were analyzed by the Mann-Whitney <i>U</i> non-parametric test. The diagnostic efficacy of APTw value was analyzed using the receiver operating characteristic (ROC) curve, and the area under the curve (AUC), threshold, sensitivity and specificity were calculated. A Spearman correlation analysis was used to assess the association between APTw and the histological grade of HCC. <b>Results</b>The APTw value of low grade HCC (2.15% ± 0.13%) was significantly lower than that of high grade HCC (2.63% ± 0.13%), and the difference was statistically significant (<i>P</i> = 0.03). The AUC for identifying high grade and low grade HCC was 0.69 (95% <i>CI</i>: 0.53 to 0.82), and with an optimal threshold of 1.85%, the sensitivity and specificity were 90.00% and 42.31%, respectively. Spearman results of the correlation analysis showed a positive correlation between APTw value and HCC pathological grade, with a correlation coefficient of <i>r </i>= 0.43 (<i>P </i>= 0.003). <b>Conclusions</b>The APTw value can be used to identify high grade and low grade HCC, and the 3D-APTw imaging has some value in predicting the preoperative pathological grade of HCC. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Preliminary study on deep learning-based enhanced 3D-MRA segmentation in patients with Budd-Chiari syndrome]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.009</link>
<description><![CDATA[<b>Objective</b>To evaluate the segmentation performance of a deep learning (DL) model in the analysis of enhanced three dimensional-magnetic resonance angiography (3D-MRA) images of patients with Budd-Chiari syndrome (BCS), and assess the inter-observer agreement among radiologists in the evaluation of the DL model<sup><sup>,</sup></sup>s segmentation outcomes. <b>Materials and Methods</b>A retrospective analysis was conducted on MRA images from 220 BCS patients. Manual segmentation was performed by two radiologists with 8 and 12 years of experience, respectively. The DL model was trained on the features extracted from these manual segmentations to enable automatic segmentation. The performance of the DL model was assessed using the Dice similarity coefficient (DSC), sensitivity, specificity, and accuracy. Consistency comparison between the segmentation results of different radiologists and the DL model was used by the area under the curve (AUC) of receiver operating characteristics (ROC). Inter-observer agreement regarding the DL model<sup><sup>,</sup></sup>s segmentation results was evaluated using the intra-class correlation coefficient (ICC) and Wilcoxon paired test. <b>Results</b>The DL model achieved DSC values of 0.93, 0.84, and 0.65 for the liver, inferior vena cava, and hepatic veins, respectively; sensitivity values were 92%, 81%, and 73%; specificity values were 93%, 93%, and 76%; accuracy values were 95%, 94%, and 86%, and AUC values were 0.95, 0.87, 0.71, respectively. There was no statistically significant difference (<i>P </i>&gt; 0.05) in AUC values between two radiologists and DL model in liver and vascular recognition of BCS patients. The subjective assessments of the DL model<sup><sup>,</sup></sup>s segmentation results by the two radiologists showed no statistically significant differences (<i>P </i>&gt; 0.05). The overall ICC was 0.94 (95% <i>CI</i>: 0.92 to 0.95). <b>Conclusions</b>The DL model exhibited robust segmentation performance in enhanced 3D-MRA images of BCS patients. Furthermore, there was excellent inter-observer agreement among radiologists of the images segmented by the DL model. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Assessing the efficacy of MRI radiomics for KRAS mutation prediction in colorectal cancer: insights from a systematic review and Meta-analysis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.010</link>
<description><![CDATA[<b>Objective</b>To assess the research quality of utilizing MRI radiomics for non-invasive prediction of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer and evaluate the diagnostic accuracy of associated prediction models. <b>Materials and Methods</b>A comprehensive literature search was conducted utilizing databases including PubMed, Embase, The Cochrane Library, Web of Science, Scopus, CNKI, and WanFang Data. This search aimed to identify all relevant studies that satisfied the established inclusion and exclusion criteria regarding the use of MRI for predicting KRAS gene mutations in colorectal cancer, covering the period from January 2015 to October 2024. The methodological quality of the selected studies was evaluated using the quality assessment of diagnostic accuracy studies 2 (QUADAS-2) and radiomics quality score (RQS) tools. Furthermore, heterogeneity among the included studies was assessed, and pooled weighted sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated using Stata 18 software, along with a summary receiver operating characteristic (SROC) analysis. <b>Results</b>A total of 17 studies, encompassing 2684 cases, were included in the analysis. The sensitivity, specificity area under the curve (AUC) values of preoperative prediction of KRAS gene status in rectal cancer utilizing MRI radiomics were 79% [95% confidence interval (<i>CI</i>): 75% to 83%], 74% (95% <i>CI</i>: 68% to 80%), and 0.85 (95% <i>CI</i>: 0.81 to 0.88), respectively. Both sensitivity and specificity combined results showed moderate heterogeneity, with <i>I</i>² heterogeneity statistics values of 56.80% (95%<i> CI</i>: 34.08% to 79.53%) and 77.35% (95%<i> CI</i>: 67.22% to 87.48%), respectively; Q values were 39.35 (<i>P</i> &lt; 0.001) and 75.05 (<i>P</i> &lt; 0.001), respectively. The results of subgroup analysis and univariate Meta-analysis indicated that all variables had a certain impact on heterogeneity (<i>P</i> &lt; 0.05). Deek<sup><sup>,</sup></sup>s funnel plot was basically symmetrical, and the slope coefficient was not statistically significant (<i>P</i> = 0.11), suggesting that there was no significant publication bias in the studies included in our analysis. <b>Conclusions</b>MRI radiomics shows strong potential for non-invasive KRAS status prediction in rectal cancer, though study heterogeneity exists. Future research should focus on improving research quality and validating models with multicenter datasets to boost accuracy and reliability. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A study on the histogram of DCE-MRI pharmacokinetic parameters for predicting endocrine therapy response in prostate cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.011</link>
<description><![CDATA[<b>Objective</b>To explore the value of predicting the response of prostate cancer (PCa) to endocrine therapy based on the histogram features of pharmacokinetic parameters of dynamic contrast enhancement magnetic resonance imaging (DCE-MRI). <b>Materials and Methods</b>Retrospectively collect the clinical and imaging data of PCa patients from Zhangye People<sup><sup>,</sup></sup>s Hospital Affiliated to Hexi University from January 2018 to October 2023 and Gansu Provincial People<sup><sup>,</sup></sup>s Hospital from February 2020 to February 2023, two weeks before endocrine therapy. A total of 105 cases were collected from Zhangye People<sup><sup>,</sup></sup>s Hospital Affiliated to Hexi University, which were divided into a training set (73 cases) and an internal validation set (32 cases) at a ratio of 7∶3. A total of 47 cases were collected from Gansu Provincial People<sup><sup>,</sup></sup>s Hospital as an external validation set. Select the original DCE-MRI images, and obtain the pseudo-color maps of pharmacokinetic parameters including volume transfer constant (K<sup>trans</sup>), rate constant (K<sub>ep</sub>), and extravascular extracellular volume fraction (V<sub>e</sub>) through the Siemens Syngovia workstation. In the 3D Slicer software, referring to the axial T2-weighted imaging (T2WI), delineate the region of interest (ROI) of the whole prostate gland layer by layer on the pseudo-color maps of pharmacokinetic parameters, and then extract the histogram features. Through dimensionality reduction by the least absolute shrinkage and selection operator (LASSO), 8 optimal features were screened out and the histogram features was calculated. Univariate and backward multivariate logistic regression were used to analyze the independent predictive factors of the good-response group and the poor-response group of endocrine therapy, and a clinical model, a histogram features model, and a combined model were constructed. The area under the curve (AUC) was calculated using the receiver operating characteristic (ROC) curve, and the calibration curve and decision curve were used to evaluate the performance of the model. The efficacy of each model was evaluated by the DeLong test. Finally, a nomogram was drawn based on the independent predictive factors of the combined model. <b>Results</b>In the training set, internal validation set, and external validation set, there were statistically significant differences in Gleason score, MRI-T stage, and histogram features between the good-response group and the poor-response group (<i>P </i>&lt; 0.001). Backward multivariate logistic regression analysis showed that the Gleason score (OR = 0.925, 95% <i>CI</i>: 0.859 to 0.958, <i>P </i>= 0.038), MRI-T stage (OR = 0.871, 95% <i>CI</i>: 0.800 to 0.949, <i>P </i>= 0.002), and histogram features (OR<i> </i>= 0.096, 95% <i>CI</i>: 0.056 to 0.137, <i>P </i>&lt; 0.001) were independent predictive factors for the response of PCa to endocrine therapy. The AUCs of the clinical model in the training set, internal validation set, and external validation set were 0.857 (95% <i>CI</i>: 0.774 to 0.939), 0.953 (95% <i>CI</i>: 0.888 to 0.996), and 0.808 (95% <i>CI</i>: 0.676 to 0.941), respectively. The AUCs of the histogram features model in the training set, internal validation set, and external validation set were 0.874 (95% <i>CI</i>: 0.769 to 0.951), 0.816 (95% <i>CI</i>: 0.664 to 0.967), and 0.674 (95% <i>CI</i>: 0.517 to 0.831), respectively. The AUCs of the combined model in the training set, internal validation set, and external validation set were 0.951 (95% <i>CI</i>: 0.906 to 0.994), 0.973 (95% <i>CI</i>: 0.922 to 0.995), and 0.830 (95% <i>CI</i>: 0.699 to 0.960), respectively. The analysis of the decision curve and calibration curve showed that the combined model had good clinical application value and stability. The DeLong test and NRI value showed that the predictive efficacy of the combined model was better than that of the clinical model and the histogram features model. <b>Conclusions</b>The histogram features of DCE-MRI pharmacokinetic parameters is an independent predictive factor for predicting the response of PCa to endocrine therapy. The combined model has good value in predicting the response of PCa to endocrine therapy, providing new ideas for clinical treatment decisions. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Predictive value of ADCmean combined with PSAD in clinically significant prostate cancer with PI-RADS score ≥ 3]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.012</link>
<description><![CDATA[<b>Objective</b>To investigate the predictive value of mean apparent diffusion coefficient (ADCmean) combined with prostate specific antigen density (PSAD) for clinically significant prostate cancer (csPCa) with a prostate imaging reporting and data system version (PI-RADS) score ≥ 3. <b>Materials and Methods</b>Clinical data and imaging data of patients with PI-RADS score ≥ 3 on prostate MRI performed at our hospital between February 2022 and August 2024 and with pathologic histology were retrospectively analyzed. The highest PI-RADS score and the largest dimension of the largest lesion were selected for ROI outlining, and the ADCmean and apparent diffusion coefficient min (ADCmin) of the lesion were measured. Univariate and multivariate logistic regression analyses were performed to identify the best clinical and imaging predictors of csPCa. Receiver operating characteristics (ROC) curves and the DeLong test were used to compare the diagnostic efficacy of the best clinical and imaging predictive models and their combined models by calculating the area under the curve (AUC), sensitivity and specificity. <b>Results</b>A total of 75 (48.39%) csPCa patients and 80 (51.61%) non-csPCa patients were included in this study. age, total prostate specific antigen (tPSA), free prostate specific antigen (fPSA), and PSAD were greater in the csPCa group than in the non-csPCa group, and prostate volume (PV), fPSA and tPSA ratio (f/t), ADCmin, and ADCmean were smaller in the csPCa group than in the non-csPCa group, and the differences were statistically significant (<i>P</i> &lt; 0.05). Stepwise logistic regression analysis and comparison of ROC curves yielded the best clinical indicator PSAD and imaging indicator ADCmean for predicting csPCa, with an AUC of 0.846 for PSAD and 0.898 for ADCmean, and an optimal cutoff value of 0.307 ng/mL<sup>2</sup> for PSAD, with a sensitivity of 66.67% and a specificity of 91.25%; ADCmean had an optimal cutoff value of 773.5 mm<sup>2</sup>/s, a sensitivity of 86.67%, and a specificity of 85.00%; the AUC of the two combined models was as high as 0.925, and the difference in diagnostic efficacy between the combined model and the single model was statistically significant using DeLong<sup><sup>,</sup></sup>s test (<i>P</i> &lt; 0.05). The sensitivity and specificity of the combined model for predicting csPCa were 86.67% and 88.75%. <b>Conclusions</b>The predictive efficacy of ADCmean for csPCa with PI-RADS ≥ 3 points was better than that of ADCmin, and the combined model with PSAD can further improve the predictive value of csPCa with PI-RADS ≥ 3 points, which is instructive for clinical diagnosis and treatment. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application of nomogram model based on ADC histogram features in predicting clinically significant prostate cancer in transitional zone]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.013</link>
<description><![CDATA[<b>Objective</b>To develop a nomogram model using apparent diffusion coefficient (ADC) histogram features to predict clinically significant prostate cancer (CSPCa) in the transition zone. <b>Materials and Methods</b>A retrospective analysis was conducted on 283 patients with suspicious prostate cancer admitted to the urology department of our hospital from January 2019 to June 2024. The patients were randomly divided into a development set (70%, 198 cases) and an internal validation set (30%, 85 cases). The least absolute shrinkage and selection operator (LASSO) algorithm was applied to screen for key features: ADC_min (apparent diffusion coefficient minimum), ADC_CoeffOfVar (coefficient of variation of apparent diffusion coefficient), ADC_kurtosis (apparent diffusion coefficient kurtosis) and ADC_entropy (apparent diffusion coefficient entropy). Furthermore, univariate and multivariate logistic regression analyses were performed to select variables and construct a predictive model. Diagnostic performance was evaluated using area under the curve (AUC) of the receiver operating characteristic (ROC), sensitivity, specificity, positive predictive value, negative predictive value, and accuracy. Decision curve analysis (DCA) was also employed to assess clinical net benefit. <b>Results</b>ADC_CoeffOfVar [odds ratio (OR) = 1.01, <i>P </i>= 0.034] and ADC_entropy (OR = 1.00, <i>P </i>&lt; 0.001) were independent predictors of CSPCa. The nomogram model constructed based on these factors demonstrated good predictive performance in both the development set (AUC = 0.844) and the internal validation set (AUC = 0.765). Calibration curve analysis showed a high degree of agreement between model predictions and actual observations, and decision curve analysis further confirmed the net benefit of the model in clinical decision-making. <b>Conclusions</b>The nomogram model constructed based on ADC histogram features not only provides a non-invasive tool for preoperative risk assessment but also holds practical clinical application potential. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Preliminary exploration of predicting clinical efficacy after acupuncture and rehabilitation therapy for lumbar disc herniation based on Radiomics Features of MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.014</link>
<description><![CDATA[<b>Objective</b>To explore the value of an radiomics model based on MRI transverse axial plain scan in predicting the clinical efficacy of acupuncture and moxibustion rehabilitation therapy for lumbar disc herniation (LDH). <b>Materials and Methods</b>A retrospective analysis was conducted on 155 LDH patients who had completed one courses of acupuncture and moxibustion rehabilitation treatment in hospital (102 cases were effective and 53 cases were ineffective). In R software, the patients were divided into a training set (<i>n </i>= 108) and a testing set (<i>n </i>= 47) using the sample function at a ratio of 7∶3. For each patient, 851 radiomics features were extracted using 3D-Slicer software based on the pre-treatment magnetic resonance T2WI transverse axial image. After removing redundant features using Pearson or Spearman correlation analysis, the least absolute shrinkage and selection operator (LASSO) regression analysis was used to further reduce the dimensionality of the features and construct the model. The receiver operating characteristic (ROC) curve was applied to the training and testing sets to validate the model and evaluate the efficacy of radiomics features in predicting the clinical efficacy of acupuncture rehabilitation therapy for LDH. <b>Results</b>After feature selection, 7 radiomics features were used to construct a clinical efficacy prediction model for LDH acupuncture and moxibustion rehabilitation therapy. The area under the ROC curve (AUC) of the prediction model in the training set was 0.862 [95% confidence interval (<i>CI</i>): 0.789 to 0.935], with sensitivity and specificity of 82.5% and 75.0%, respectively; the AUC of the test set was 0.887 (95% <i>CI</i>: 0.773 to 0.989), with sensitivity and specificity of 92.3% and 79.4%, respectively. <b>Conclusions</b>Based on the MRI axial imaging-based radiomics model, it exhibits excellent predictive performance for the clinical efficacy of acupuncture and rehabilitation therapy for LDH, serving as a robust basis for clinical decision-making. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Study of application on neonatal head coil in brain MRI examination]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.015</link>
<description><![CDATA[<b>Objective</b>To investigate the clinical value of 16-channel neonatal head coil for neonatal cranial magnetic resonance imaging (MRI). <b>Materials and Methods</b>Using the water film detection method, proton density weighted imaging (PDWI) sequence was selected, and the same parameters were set. The neonatal head coil and adult head coil were respectively tested in vitro. The signal-to-noise ratio (SNR) of the two coils was obtained by processing the images for objective quantitative analysis. A total of 44 healthy neonates undergoing brain magnetic resonance examination from August 2022 to December 2023 were prospectively collected and divided into 2 groups by simple random method. To test image SNR and contrast-to-noise ratio (CNR) of gray and white matter. The T2WI sequence images with acceleration factor R = 2 were collected for both groups using neonatal head coil and adult head coil with the same parameters. Then the acceleration factor R = 2, 3, 4, 5, 6 was adjusted respectively to test the parallel acquisition capability of the coil. Neonatal brain images were comprehensively analyzed, image SNR and gray and white matter CNR of the two coils were calculated, and the parallel acquisition ability of the two coils was independently evaluated by two imaging diagnostic physicians, and the subjective score of image SNR and gray and white matter CNR was statistically analyzed by <i>t-</i>test. <b>Results</b>In vitro experiment, the SNR of neonatal head coil was 1.4 times higher than that of adult head coil, and some cortical surface areas were more than 2 times. In clinical experiments, the SNR of neonatal head coil in bilateral thalamus, basal ganglia and frontal lobe region were higher than those of adult head coil, the CNR of gray matter in bilateral thalamus and basal ganglia and white matter in frontal lobe of neonatal head coil is higher than that of adult head coil, and the differences was statistically significant (<i>P </i>&lt; 0.001). After adjusting the acceleration factor, the neonatal head coil showed high parallel acquisition capability. <b>Conclusions</b>Neonatal head coil can improve the quality of neonatal brain magnetic resonance image. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of quantitative magnetic resonance technique in the diagnosis of Parkinson<sup><sup>,</sup></sup>s disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.017</link>
<description><![CDATA[Parkinson<sup><sup>,</sup></sup>s disease (PD) is the second most common neurological illness among middle-aged and elderly persons worldwide. In the early stages of the disease, it may only manifest as a slight tremor in the hands, making it easy to overlook; however, as the disease progresses, the patient<sup><sup>,</sup></sup>s walking, thinking, sleeping, and so on will be affected, and eventually, he or she will be unable to care for himself or herself due to the inability to move around and become bedridden for an extended period of time. As a result, correct disease identification at an early stage can lead to better therapy, reduce disease progression, and improve prognosis. Quantitative MRI approaches can give non-invasive information on neuronal activity and metabolite changes in PD brain tissue, as well as the underlying biological characteristics of the disorders. In this article, we will look at how quantitative MRI techniques can aid with early PD diagnosis, lesion evaluation, treatment, and prognosis in clinical practice. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of Functional Connectivity in self-limited epilepsy with centrotemporal spikes]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.018</link>
<description><![CDATA[Self-limited epilepsy with centrotemporal spikes (SeLECTS) is the most common age-dependent, self-limited focal epilepsy of childhood, characterised by interictal centrotemporal (Rolandic) spikes on the EEG. Although SeLECTS is considered self-limiting, some children have cognitive deficits in language, reading, visuospatial, executive function and attention. These deficits may be related to abnormalities in functional connectivity (FC), which can be paradoxically increased and decreased in different brain regions at the same time. This paper briefly introduces common functional connectivity research methods, summarises the strengths and weaknesses of these methods, and also summarises the research progress of FC in SeLECTS over the past years, with the aim of exploring the potential of FC as a biomarker for predicting cognitive and seizure outcomes. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Neuroimaging advances in acupuncture for mild cognitive impairment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.019</link>
<description><![CDATA[Mild cognitive impairment (MCI) refers to the progressive decline of memory or other cognitive functions, which belongs to the early stage of Alzheimer<sup><sup>,</sup></sup>s disease and is the key window of early diagnosis, prevention and treatment, and there is no drug radical cure. Acupuncture is widely used for its wide indications, quick response and simple operation, but its clinical treatment mechanism is still unclear. In recent years, with the rapid development of multimodal imaging technology and the continuous deepening of neuroimaging research on acupuncture treatment of MCI, the acupuncture treatment effect of MCI brain is accurately evaluated based on objective information such as structure, function and molecular imaging. It<sup><sup>,</sup></sup>s convenient for early/ultra-early clinical treatment and intervention, provides objective evidence for the discussion of disease pathogenesis. This paper reviews the research progress of brain functional imaging technology in treating MCI patients with acupuncture, in order to provide new ideas for further revealing the mechanism of acupuncture on MCI diseases and a new perspective for clinical accurate diagnosis and treatment. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on the correlation between multimodal MRI brain imaging and inflammatory markers in depression]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.020</link>
<description><![CDATA[The incidence rate of depression and suicide rate have been rising year by year, and this has become a serious global public health issue. In recent years, some studies have shown that peripheral blood inflammatory markers are closely related to the pathophysiological processes of depression. The correlation between inflammatory markers and depression can be characterized by multimodal MRI, which further deepens the exploration into the progression of depression, the selection of treatment targets, and prognosis assessment. This review briefly summarizes recent research on the correlation between inflammatory markers and the imaging characteristics of multimodal MRI in depression, as well as potential limitations, aiming to provide direction for future studies. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress on multimodal imaging technology in the brains of Crohn<sup><sup>,</sup></sup>s disease patients with negative emotions]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.021</link>
<description><![CDATA[Patients with Crohn<sup><sup>,</sup></sup>s disease (CD) often experience negative emotions such as anxiety and depression, which not only potentially compromise their mental health but also aggravate the disease progression and diminish their quality of life. Currently, clinical recognition of the negative emotions commonly associated with CD is limited. Standard anti-inflammatory treatments are ineffective in alleviating these symptoms, and the diagnostic methods available are subjective and restricted. Therefore, finding objective assessment methods to guide clinical diagnosis and treatment has become a critical issue. An increasing number of studies suggest that the development of negative emotions in CD patients is closely linked to structural and functional changes in specific brain regions. Currently, multimodal imaging techniques, such as structural magnetic resonance imaging, functional magnetic resonance imaging, and near-infrared spectroscopy, have been widely applied in the study of brain function and structural changes, demonstrating significant clinical value. This review will summarize the recent findings based on multimodal imaging techniques that have identified brain structural and functional changes associated with negative emotions such as anxiety and depression in CD patients. These findings provide neuroimaging-based evidence for future assessments and treatments of CD patients with comorbid negative emotions. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in imaging-transcriptomics association studies in neurodegenerative diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.022</link>
<description><![CDATA[The application of multimodal MRI and other imaging techniques to detect brain phenotypic alterations in patients with neurodegenerative diseases has become pervasive in clinical diagnosis and scientific research. However, the genetic mechanisms underlying these brain phenotypic changes still remain unknown. In recent years, with the advent of brain-wide transcriptomics data (i.e., the Allen Human Brain Atlas), the field of imaging-transcriptomics association studies has emerged as a cross-disciplinary area aiming to bridge the gap between macroscopic neuroimaging phenotypes and microscopic molecular expression, which has achieved certain advancements. This review systematically summarizes the methodological framework of imaging transcriptome association studies and its latest advances in Alzheimer<sup><sup>,</sup></sup>s disease, Parkinson<sup><sup>,</sup></sup>s disease, Huntington<sup><sup>,</sup></sup>s disease and other diseases, aiming to provide researchers with neurodegenerative disease researchers with theoretical tools for cross-scale research, and provide new perspectives for elucidating disease mechanisms and developing targeted therapy strategies. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on multimodal MRI of cognitive impairment in type 2 diabetes mellitus]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.023</link>
<description><![CDATA[Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and dysfunction of β cells.In recent years, studies on brain damage in T2DM patients have gradually increased, such as voxel-based morphometry, brain structural networks, arterial spin labeling, quantitative magnetization transfer imaging, neurovascular coupling, etc, in multimodal MRI, as well as the monitoring and analysis of T2DM patients with cognitive impairment in terms of artificial intelligence and gut microbiota in multimodal MR. These are emerging methods for predicting and evaluating brain damage in T2DM patients. This article summarizes the latest application progress of multimodal MRI in brain structure, cerebral perfusion, iron deposition, neurovascular coupling, artificial intelligence, and gut microbiota in T2DM patients, with the aim of revealing the neurophysiological mechanism, making more accurate judgments on the disease progression of patients, formulating the best treatment strategies for patients, improving the prognosis of patients, and providing reference directions for future research. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in brain MRI research of metabolic dysfunction-associated steatotic liver disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.024</link>
<description><![CDATA[As a hepatic manifestation of systemic metabolic disorders, metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease. Previous studies have shown that MASLD may be associated with dementia and cognitive impairment. The brain structure and function abnormalities in MASLD patients can be observed by MRI to better explore the pathological mechanism of cognitive impairment in MASLD. This article reviews the advances in MRI studies on brain structure, function and cerebral perfusion in patients with MASLD, providing a neuroimaging foundation for exploring the mechanisms linking MASLD to dementia and optimizing therapeutic strategies for cognitive impairment in MASLD patients. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The research progress of radiomics and pathomics in glioma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.025</link>
<description><![CDATA[Glioma is the most common primary malignant brain tumor with high incidence and poor prognosis. Preoperative prediction of glioma grading, molecular typing, tumor microenvironment and prognosis is of significant clinical importance for making personalized treatment decisions. The technological advancements in radiomics and pathomics are reshaping the approaches for glioma diagnosis and prognosis evaluation. Radiomics involves the quantification and analysis of high-dimensional features from imaging data, while pathomics extracts microscopic pathological features from tissue slide images. The combination of these two approaches enables non-invasive and precise tumor assessment. This review summarizes the research progress of radiomics and pathomics in glioma, aiming to provide accurate diagnosis, treatment, and individualized management for glioma patients. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in functional magnetic resonance imaging in carotid artery stenosis and associated cognitive impairment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.026</link>
<description><![CDATA[Carotid artery stenosis (CAS) is a common vascular disease, which is not only closely related to the occurrence of ischaemic stroke, but also significantly associated with cognitive dysfunction, which seriously affects the quality of life of patients. Asymptomatic carotid stenosis (ACS) is carotid artery disease that has not yet resulted in a transient ischemic attack (TIA), ischemic stroke, or dementia. Even in asymptomatic patients with CAS, it can lead to significant cognitive dysfunction. In order to prevent further progression towards dementia, there is an urgent need to study the relationship between CAS and cognition. With the development of modern brain imaging technology, functional magnetic resonance imaging (fMRI) technology is able to sensitively detect abnormalities in brain tissue perfusion, structure and function, provided key imaging evidence to elucidate the mechanisms of CAS-related cognitive impairment. The purpose of this article is to review the latest research progress of fMRI technology in carotid artery stenosis and related cognitive impairment in recent years, in anticipation of providing new ideas for the assessment and diagnosis of CAS. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in research on the application of cardiac magnetic resonance imaging in the subclinical stage of diabetic cardiomyopathy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.027</link>
<description><![CDATA[Diabetic cardiomyopathy (DCM), as one of the common complications of diabetes mellitus (DM), manifests early as asymptomatic myocardial injury and functional abnormalities. The early diagnosis and intervention of DCM are crucial for prognosis. Due to the insufficient sensitivity of traditional imaging techniques in detecting subclinical myocardial lesions, multiparametric cardiac magnetic resonance (CMR) has emerged as a significant tool for early identification of the subclinical stage of DCM in recent years. This is attributed to its non-invasiveness, high resolution, and multifunctional imaging capabilities. Its importance has been recognized in recent guidelines and expert consensuses, and relevant research continues to evolve. This article systematically reviews the research progress of CMR in the diagnosis of subclinical lesions in DCM, focusing on myocardial metabolic abnormalities, microcirculation dysfunction, myocardial fibrosis, and myocardial strain. Furthermore, it analyzes the advantages and challenges of applying CMR in the subclinical diagnosis of DCM, providing a reference for future clinical diagnosis, treatment, and research directions ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on the application of intravoxel incoherent motion in myocardial microcirculation]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.028</link>
<description><![CDATA[Myocardial microcirculatory dysfunction serves as an independent risk factor for adverse cardiovascular events such as heart failure and cardiogenic sudden death. Early quantitative assessment of myocardial microcirculation has therefore become a research hotspot in cardiovascular imaging. Intravoxel incoherent movement (IVIM) magnetic resonance imaging, a technique capable of evaluating tissue microcirculatory function, provides a non-invasive, multi-parametric, and dynamically assessable novel perspective for early diagnosis of myocardial microcirculatory dysfunction. This paper systematically elaborates on the repeatability and stability of IVIM in myocardial microcirculation assessment, explores the quantitative characteristics of myocardial microcirculation under different pathological conditions using IVIM, and highlights the unresolved issues and emerging research directions in current IVIM-based myocardial microcirculation evaluations. This comprehensive review aims to enable subsequent researchers to grasp the latest developments in this field. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Cardiac magnetic resonance in evaluating cardioxicity induced by anthracycline chemotherapy in breast cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.029</link>
<description><![CDATA[Breast cancer is the most common malignancy in Chinese women. As the commonest chemotherapy drugs for breast cancer, anthracyclines can effectively control tumor progression and improve the long-term prognosis of patients. However, anthracyclines have some cardiotoxicity and are associated with various degrees of myocardial damage during tumor chemotherapy, affecting patients<sup><sup>,</sup></sup> quality of life. Therefore, early detection of myocardial damage caused by anthracyclines is helpful for early clinical intervention and protection of patients<sup><sup>,</sup></sup> heart function. Cardiac magnetic resonance (CMR) has potential value in early detection of myocardial damage due to its non-radiative, non-invasive, multi-parameter, multi-sequence imaging advantages. This review reviews the value of CMR in assessing cardiotoxicity in breast cancer patients treated with anthracyclines, in order to enhance the awareness of radiologist and clinicians regarding myocardial injury in such patients and improve the appliaction of CMR in the assement of myocardial injury caused by chemotherapy for breast cancer. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress in MRI diagnosis of breast non-mass enhancement lesions]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.030</link>
<description><![CDATA[Breast diseases pose a serious threat to women<sup><sup>,</sup></sup>s health. Among them, non-mass enhancement (NME) lesions of the breast have always been difficult to diagnose and differentiate due to their complex and diverse pathological types and atypical imaging features. In recent years, functional imaging techniques represented by intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI), as well as artificial intelligence (AI) algorithms, have significantly improved the diagnostic efficiency of magnetic resonance imaging (MRI) for NME lesions. Based on this, this paper systematically reviews the research progress of MRI techniques in NME lesions, focuses on discussing the clinical application values of functional imaging, multimodal fusion, and AI models, and proposes future optimization directions in response to technical bottlenecks, aiming to provide references for the clinical practice and scientific research of NME lesions. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in imaging research on congenital anorectal malformations]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.031</link>
<description><![CDATA[Congenital anorectal malformations (ARM) is a common congenital digestive tract malformation, including a variety of pathological changes, usually made after birth through physical examination to make a preliminary diagnosis, but cannot be comprehensively and accurately assessed, and further imaging diagnosis is required, and preoperative imaging diagnosis is essential to guide the surgical treatment. In recent years, the preoperative imaging diagnosis of ARM has been developing both at home and abroad. This review focuses on the advantages and disadvantages of the latest imaging methods (X-ray, ultrasound, high-pressure distal colonography, MRI) in the neonatal period, and focused on the role of MRI in the assessment of perianal and pelvic floor muscles in children with ARM. We found that the current diagnosis of ARM is still faced with the challenges of insufficient standardization of the examination procedures and lack of data on the development of the perianal and pelvic floor muscles. Parameters of magnetic resonance on perianal and pelvic floor muscle development in children with ARM and healthy newborns. The aim of this review is to provide assistance for future diagnostic imaging and research in ARM. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application and progress of multi-parametric magnetic resonance imaging in predicting extracapsular extension of prostate cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.032</link>
<description><![CDATA[Prostate cancer (PCa) is one of the most common cancers among men globally, and accurately assessing extracapsular extension (ECE) is crucial for optimizing treatment plans. Traditional clinical diagnostic parameters have limitations such as low accuracy and high heterogeneity. Multi-parametric magnetic resonance imaging (mpMRI) is the preferred method for preoperative staging of PCa. However, the diagnostic efficacy of predicting ECE based on the traditional ECE risk assessment grading system using mpMRI remains limited by the experience of radiologists. With the development of emerging technologies, radiomics and deep learning (DL) have demonstrated potential in assessing ECE, but still face challenges such as insufficient external validation and weak model generalization ability. This article reviews the current research status, progress, and limitations of traditional risk assessment grading systems, radiomics, and DL based on mpMRI in diagnosing PCa ECE. The aim is to provide more comprehensive references for clinical decision-making, and accelerate the vigorous progress of precision medicine. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in non-Gaussian diffusion models for cervical cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.033</link>
<description><![CDATA[Non-Gaussian diffusion models are derived from traditional magnetic resonance diffusion-weighted imaging (DWI). Currently, there are several models such as intravoxel incoherent motion (IVIM), continuous-time random walk (CTRW), diffusion-kurtosis imaging (DKI), fractional order calculus (FROC), stretched exponential model (SEM), diffusion tensor imaging-angi perivascular space, white matter tract integrity, and mean apparent propagator MRI and so on. Compared to traditional diffusion models, these Non-Gaussian diffusion models can more accurately capture complex diffusion processes, effectively reflecting the complexity and heterogeneity of tissue microstructures, and providing additional tissue structural information. In recent years, IVIM, CTRW, DKI, FROC and SEM have been gradually applied in the evaluation of cervical cancer pathotyping, differentiation, lymphnode metastasis and the efficacy of radiotherapy and chemotherapy, each with its unique characteristics. Although research on these five models in cervical cancer is increasing, there is currently no systematic review of their applications and comparisons in cervical cancer evaluation. Therefore, this article will review the above five non-Gaussian diffusion models and their applications in cervical cancer, in hopes of providing references for clinical diagnosis and treatment. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress in the application of radiomics in the comprehensive treatment of advanced cervical cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.034</link>
<description><![CDATA[Cervical cancer starts insidiously and is mostly found in the advanced stage. The comprehensive treatment modes of advanced cervical cancer mainly include two categories related to surgery and radiotherapy. However, current guidelines remain controversial regarding the appropriate patient population and survival benefits of commonly used treatment strategies, such as neoadjuvant chemotherapy (NACT) before surgery or radical chemoradiotherapy and adjuvant chemotherapy (ACT) after surgery or radical chemoradiotherapy, and lack of clear consensus recommendations. Radiomics can extract high-throughput imaging features from different imaging modalities, quantitatively assess tumor lesions, aid in identifying beneficiary populations and evaluating treatment efficacy and survival outcomes. It may provide a clinical decision-making basis for the individualized treatment of comprehensive models in advanced cervical cancer. This article reviews the application of radiomics in the comprehensive treatment models associated with surgery and radiotherapy for advanced cervical cancer, aiming to offer new ideas and strategies for its comprehensive treatment. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on bone marrow magnetic resonance imaging of aplastic anemia]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.035</link>
<description><![CDATA[Aplastic anemia (AA) is a bone marrow hematopoietic failure syndrome characterized by significant reduction in whole blood cells, low bone marrow proliferation capacity, and gradual replacement of hematopoietic tissue by adipose tissue. As a blood system disease that seriously threatens the life and health of patients, the current diagnosis of AA is still limited to exclusionary diagnosis. Finding clear and specific diagnostic criteria and biomarkers is still an important issue that needs to be addressed in the field of AA research. Accurate diagnosis and effective evaluation of the condition are of great significance for optimizing treatment plans and improving the prognosis of AA patients. MRI as a non-invasive and high-resolution imaging detection method, can effectively identify physiological and pathological changes in bone marrow based on different features provided by different sequences used, and analyze the internal structure of bone marrow. This detection method can effectively avoid the trauma and limitations of bone marrow puncture and other examinations. This article reviews the various applications of MRI in the field of bone marrow imaging research for AA, including the evaluation of AA lesions, determination of disease classification, dynamic monitoring of treatment efficacy, and differential diagnosis with other related hematological diseases. The aim is to provide reliable imaging theoretical basis for further in-depth research on the pathological basis of AA. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in the application of multimodal magnetic resonance imaging for nerve root assessment before and after minimally invasive surgery for lumbar disc herniation]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.036</link>
<description><![CDATA[Lumbar disc herniation (LDH) is a common spinal disorder that significantly impacts patients<sup><sup>,</sup></sup> quality of life. With advancements in minimally invasive surgical techniques, percutaneous endoscopic lumbar discectomy (PELD) has emerged as a mainstream treatment option due to its advantages of minimal trauma and rapid recovery. However, conventional imaging techniques have limitations in assessing nerve root function, making it difficult to comprehensively evaluate the microstructure and functional status of nerve roots. Multimodal magnetic resonance imaging (MRI) techniques, such as magnetic resonance neurography (MRN), diffusion tensor imaging (DTI), and diffusion tensor tractography (DTT), integrate morphological and functional assessments to more accurately visualize nerve root compression, injury severity, and postoperative recovery. These methods provide critical insights for LDH diagnosis, surgical planning, and treatment efficacy evaluation. In recent years, the application of artificial intelligence (AI) in medical image analysis has brought breakthroughs in automated LDH detection and nerve root assessment. Deep learning-based image reconstruction and segmentation techniques have significantly improved image quality and diagnostic efficiency. Future research should focus on optimizing AI algorithms and exploring their potential in conjunction with multimodal MRI for pre- and postoperative nerve root evaluation in LDH, aiming to enhance diagnostic accuracy and therapeutic outcomes. This article provides a systematic review of the current application status of multimodal MRI in the evaluation of nerve roots before and after minimally invasive LDH surgery, analyzes its advantages and limitations, and explores the future development direction of combining with artificial intelligence. The aim is to provide reference for optimizing clinical diagnosis and treatment decisions and exploring the mechanism of nerve root injury in scientific research. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of PCASL imaging technology artifact and its clinic]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.04.037</link>
<description><![CDATA[Arterial spin labeling (ASL) is a non-invasive magnetic resonance perfusion imaging technique that uses magnetically labeled water in flowing blood as an endogenous tracer to assess cerebral blood flow (CBF). At present, it has demonstrated unique clinical value in cerebrovascular diseases, brain tumors, epilepsy and neurodegenerative diseases. With the continuous development of technology, it can be divided into four categories according to different pulse methods, and the most commonly used technology in clinical practice is pseudocontinuous ASL (PCASL). Although PCASL technology has shown great potential in clinical applications, it still faces the problem of artifact generation during imaging. These artifacts may occur at all stages of imaging, and can be divided into three main categories: during labeling, during arterial transmission, and during readout, and the causes and manifestations of artifacts are complex. Therefore, it is of great significance to further improve the accuracy and reliability of PCASL technology in clinical applications. This article reviews the performance characteristics, causes, remedial measures, and potential clinical value of PCASL technical artifacts, in order to explore its clinical value and improve the practicability and reliability of PCASL in the field of neuroimaging. ]]></description>
<pubDate>Sun,20 Apr 2025 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
